These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6785906)

  • 1. Fetal death due to extreme maternal Rh immune augmentation.
    Branch DR
    Transfusion; 1981; 21(3):281-4. PubMed ID: 6785906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
    Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
    Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three examples of Rh haemolytic disease of the newborn with a negative direct antiglobulin test.
    Heddle NM; Wentworth P; Anderson DR; Emmerson D; Kelton JG; Blajchman MA
    Transfus Med; 1995 Jun; 5(2):113-6. PubMed ID: 7655573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal CW alloimmunization.
    Bowman JM; Pollock J
    Vox Sang; 1993; 64(4):226-30. PubMed ID: 8517051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consequences for fetus and neonate of maternal red cell allo-immunisation.
    Howard H; Martlew V; McFadyen I; Clarke C; Duguid J; Bromilow I; Eggington J
    Arch Dis Child Fetal Neonatal Ed; 1998 Jan; 78(1):F62-6. PubMed ID: 9536844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolytic disease of the fetus and newborn due to multiple maternal antibodies.
    Markham KB; Rossi KQ; Nagaraja HN; O'Shaughnessy RW
    Am J Obstet Gynecol; 2015 Jul; 213(1):68.e1-68.e5. PubMed ID: 25644438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-G in a pregnant patient.
    Cash K; Brown T; Strupp A; Uehlinger J
    Transfusion; 1999 May; 39(5):531-3. PubMed ID: 10336005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple antibody formation in a primigravida: anti-D, anti-C, anti-Kpb.
    Musclow CE; Abbott D; Tobin SM
    Obstet Gynecol; 1982 Jun; 59(6 Suppl):10S-2S. PubMed ID: 6806732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal hemolytic disease due to anti-Rh17 alloimmunization.
    Hirose M; Nakanishi K; Kaku S; Moro H; Hodohara K; Aotani H; Takebayashi K; Noda Y
    Fetal Diagn Ther; 2004; 19(2):182-6. PubMed ID: 14764967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of Rh0(D) sensitization: a cost-effective analysis.
    Lim OW; Fleisher AA; Ziel HK
    Obstet Gynecol; 1982 Apr; 59(4):477-80. PubMed ID: 6176925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolytic disease of the newborn due to anti-C and anti-G masquerading as anti-D.
    Yesus YW; Akhter JE
    Am J Clin Pathol; 1985 Dec; 84(6):769-72. PubMed ID: 3934960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with intrauterine transfusions for severe Rh alloimmunization in a developing country.
    Gupte SC; Lulla CP; Kulkarni SS; Korgaonkar SA; Walvekar VR; Merchant RH
    J Matern Fetal Med; 1998; 7(6):287-91. PubMed ID: 9848694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemolytic disease of the newborn from anti-E. A case report.
    Strohm PL; Iams JD; Kennedy MS
    J Reprod Med; 1988 Apr; 33(4):404-6. PubMed ID: 3130484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RhD haemolytic disease of the fetus and the newborn.
    Urbaniak SJ; Greiss MA
    Blood Rev; 2000 Mar; 14(1):44-61. PubMed ID: 10805260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the management of severely Rh-immunized patients.
    Scott JR; Kochenour NK; Larkin RM; Scott MJ
    Am J Obstet Gynecol; 1984 Jun; 149(3):336-41. PubMed ID: 6428230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of alloantibodies other than anti-D hemolytic disease of the fetus and newborn (HDF/N)].
    Lenkiewicz B; Zupańska B
    Ginekol Pol; 2003 Jan; 74(1):48-54. PubMed ID: 12715437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal hemolytic disease of a newborn due to anti-D in an Rh-positive Du variant mother.
    Lacey PA; Caskey CR; Werner DJ; Moulds JJ
    Transfusion; 1983; 23(2):91-4. PubMed ID: 6404025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new approach to the diagnosis of active Rh0(D) immunization in passively immunized pregnant women.
    Foung SK; Perkins S; McCallum WD; Tom S; Engleman EG; Grumet FC
    Vox Sang; 1985; 49(3):206-10. PubMed ID: 2996227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of hemolytic disease of the newborn caused by anti-M: serological study of maternal blood.
    Matsumoto H; Tamaki Y; Sato S; Shibata K
    Acta Obstet Gynaecol Jpn; 1981 Apr; 33(4):525-8. PubMed ID: 7195138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey.
    Altuntas N; Yenicesu I; Himmetoglu O; Kulali F; Kazanci E; Unal S; Aktas S; Hirfanoglu I; Onal E; Turkyilmaz C; Ergenekon E; Koc E; Atalay Y
    Transfus Apher Sci; 2013 Jun; 48(3):377-80. PubMed ID: 23619329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.